FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roger Le Verge

Research Profile

Chemicals & Drugs

Objects

Microspheres

Living Beings

Rabbits

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gilles Dollo; Pascal Le Corre; François Chevanne; Roger Le Verge
Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits.
Rozenn Clément; Jean-Marc Malinovsky; Patrice Hildgen; Gilles Dollo; Jean-Pierre Estèbe; François Chevanne; Roger Le Verge; Pascal Le Corre
Spinal disposition and meningeal permeability of local anesthetics.
Gilles Dollo; Jean-Marc Malinovsky; Alain Péron; François Chevanne; Michel Pinaud; Roger Le Verge; Pascal Le Corre
Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roger Le Verge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Gilles Dollo; Pascal Le Corre; François Chevanne; Roger Le Verge
Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;22(1):63-70.
2004: Rozenn Clément; Jean-Marc Malinovsky; Patrice Hildgen; Gilles Dollo; Jean-Pierre Estèbe; François Chevanne; Roger Le Verge; Pascal Le Corre
Spinal disposition and meningeal permeability of local anesthetics.
Pharmaceutical research 2004;21(4):706-16.
2004: Gilles Dollo; Jean-Marc Malinovsky; Alain Péron; François Chevanne; Michel Pinaud; Roger Le Verge; Pascal Le Corre
Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits.
International journal of pharmaceutics 2004;272(1-2):109-19.
2003: Jean-Pierre Estebe; Pascal Le Corre; Rozenn Clément; Laure Du Plessis; François Chevanne; Roger Le Verge; Claude Ecoffey
Effect of dexamethasone on motor brachial plexus block with bupivacaine and with bupivacaine-loaded microspheres in a sheep model.
European journal of anaesthesiology 2003;20(4):305-10.
2002: Jean-Pierre Estèbe; Marc E Gentili; Pascal Le Corre; Roger Le Verge; Jacques-Philippe Moulinoux; Claude Ecoffey
Sciatic nerve block with bupivacaine-loaded microspheres prevents hyperalgesia in an inflammatory animal model.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2002;49(7):690-3.
2002: Pascal Le Corre; Jean-Pierre Estèbe; Rozenn Clément; Laure Du Plessis; François Chevanne; Claude Ecoffey; Roger Le Verge
Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep.
International journal of pharmaceutics 2002;238(1-2):191-203.
2002: Jean-Pierre Estebe; Claude Ecoffey; Gilles Dollo; Pascal Le Corre; François Chevanne; Roger Le Verge
Bupivacaine pharmacokinetics and motor blockade following epidural administration of the bupivacaine-sulphobutylether 7-beta-cyclodextrin complex in sheep.
European journal of anaesthesiology 2002;19(4):308-10.
2002: Jean-Pierre Estebe; Gilles Dollo; Pascal Le Corre; Alain Le Naoures; François Chevanne; Roger Le Verge; Claude Ecoffey
Alkalinization of intracuff lidocaine improves endotracheal tube-induced emergence phenomena.
Anesthesia and analgesia 2002;94(1):227-30, table of contents.
2001: Jean-Pierre Estebe; Pascal Le Corre; Laure Du Plessis; François Chevanne; G Cathelineau; Roger Le Verge; Claude Ecoffey
The pharmacokinetics and pharmacodynamics of bupivacaine-loaded microspheres on a brachial plexus block model in sheep.
Anesthesia and analgesia 2001;93(2):447-55, 4th contents page.
2001: Gilles Dollo; Jean-Pierre Estebe; Pascal Le Corre; François Chevanne; Claude Ecoffey; Roger Le Verge
Endotracheal tube cuffs filled with lidocaine as a drug delivery system: in vitro and in vivo investigations.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;13(3):319-23.
2000: Rozenn Clément; Jean-Marc Malinovsky; Pascal Le Corre; Gilles Dollo; François Chevanne; Roger Le Verge
Spinal biopharmaceutics of bupivacaine and lidocaine by microdialysis after their simultaneous administration in rabbits.
International journal of pharmaceutics 2000;203(1-2):227-34.
2000: Jean-Pierre Estebe; Pascal Le Corre; François Chevanne; G Cathelineau; Roger Le Verge; Claude Ecoffey
Motor blockade by brachial plexus block in the sheep.
Anesthesiology 2000;93(1):291-3.
2000: Anne-Marie Torché; H Jouan; Pascal Le Corre; Emmanuel Albina; R Primault; André Jestin; Roger Le Verge
Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment.
International journal of pharmaceutics 2000;201(1):15-27.
2000: A M Torche; Pascal Le Corre; Emmanuel Albina; André Jestin; Roger Le Verge
PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature.
Journal of drug targeting 2000;7(5):343-54.
1999: C Lefeuvre; Pascal Le Corre; Gilles Dollo; François Chevanne; Jean-Louis Burgot; Roger Le Verge
Biopharmaceutics and pharmacokinetics of 5-phenyl-1, 2-dithiole-3-thione complexed with sulfobutyl ether-7-beta-cyclodextrin in rabbits.
Journal of pharmaceutical sciences 1999;88(10):1016-20.
1999: Pascal Le Corre; Gilles Dollo; François Chevanne; Roger Le Verge
Biopharmaceutics and metabolism of yohimbine in humans.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;9(1):79-84.
1999: Gilles Dollo; Pascal Le Corre; M Chollet; François Chevanne; M Bertault; Jean-Louis Burgot; Roger Le Verge
Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Journal of pharmaceutical sciences 1999;88(9):889-95.
1999: Elisabeth Polard; V Le Bouquin; Pascal Le Corre; C Kérebel; H Trout; A Feuillu; Roger Le Verge; Yannick Mallédant
Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Therapeutic drug monitoring 1999;21(4):395-403.
1999: Gilles Dollo; François Chevanne; Pascal Le Corre; C Chemtob; Roger Le Verge
[Bioavailability of phloroglucinol in man].
Journal de pharmacie de Belgique 1999;54(3):75-82.
1999: R Clement; Jean-Marc Malinovsky; Pascal Le Corre; Gilles Dollo; François Chevanne; Roger Le Verge
Cerebrospinal fluid bioavailability and pharmacokinetics of bupivacaine and lidocaine after intrathecal and epidural administrations in rabbits using microdialysis.
The Journal of pharmacology and experimental therapeutics 1999;289(2):1015-21.
1999: Anne-Marie Torché; Emmanuel Albina; Pascal Le Corre; André Jestin; Roger Le Verge
Flow cytometric and optical microscopic evaluation of poly(D, L-lactide-co-glycolide) microspheres phagocytosis by pig alveolar macrophages.
Journal of controlled release : official journal of the Controlled Release Society 1999;58(3):289-301.
1998: S Reif; Pascal Le Corre; Gilles Dollo; François Chevanne; Roger Le Verge
High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2',6'-pipecoloxylidide in plasma.
Journal of chromatography. B, Biomedical sciences and applications 1998;719(1-2):239-44.
1998: Rozenn Clément; Jean-Marc Malinovsky; Gilles Dollo; Pascal Le Corre; François Chevanne; Roger Le Verge
In vitro and in vivo microdialysis calibration using retrodialysis for the study of the cerebrospinal distribution of bupivacaine.
Journal of pharmaceutical and biomedical analysis 1998;17(4-5):665-70.
1997: Pascal Le Corre; J H Rytting; V Gajan; François Chevanne; Roger Le Verge
In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres.
Journal of microencapsulation 1997;14(2):243-55.
1997: Pascal Le Corre; Elaine Peskind; François Chevanne; Murray A Raskind; Roger Le Verge
Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients.
European journal of clinical pharmacology 1997;52(2):135-8.
1997: D Fletcher; Pascal Le Corre; G Guilbaud; Roger Le Verge
Antinociceptive effect of bupivacaine encapsulated in poly(D,L)-lactide-co-glycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats.
Anesthesia and analgesia 1997;84(1):90-4.
1996: J C Fréville; Gilles Dollo; Pascal Le Corre; François Chevanne; Roger Le Verge
Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex.
Pharmaceutical research 1996;13(10):1576-80.
1995: Elaine Peskind; DK Wingerson; S Murray; Marcella Pascualy; Dorcas J Dobie; Pascal Le Corre; Roger Le Verge; Richard C Veith; Murray A Raskind
Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.
Archives of general psychiatry 1995;52(9):774-82.
1995: Jean-Marc Malinovsky; Jean-Marc Bernard; Pascal Le Corre; J B Dumand; Jean-Yves Lepage; Roger Le Verge; R Souron
Motor and blood pressure effects of epidural sustained-release bupivacaine from polymer microspheres: a dose-response study in rabbits.
Anesthesia and analgesia 1995;81(3):519-24.
1995: Pascal Le Corre; J P Estèbe; François Chevanne; Yannick Mallédant; Roger Le Verge
Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres.
Journal of pharmaceutical sciences 1995;84(1):75-8.
1993: P Le Guévello; Pascal Le Corre; François Chevanne; Roger Le Verge
High-performance liquid chromatographic determination of bupivacaine in plasma samples for biopharmaceutical studies and application to seven other local anaesthetics.
Journal of chromatography 1993;622(2):284-90.
1993: Pascal Le Corre; Yannick Malledant; Michèle Tanguy; Roger Le Verge
Steady-state pharmacokinetics of dopamine in adult patients.
Critical care medicine 1993;21(11):1652-7.
1993: Pascal Le Corre; Yannick Malledant; Michèle Tanguy; Roger Le Verge
Non linear disposition of thiopentone following long-term infusion.
European journal of drug metabolism and pharmacokinetics 1993;18(3):255-9.
1993: M Berlan; Roger Le Verge; J Galitzky; Pascal Le Corre
Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.
British journal of pharmacology 1993;108(4):927-32.
1992: Roger Le Verge; Pascal Le Corre; François Chevanne; M Döe De Maindreville; D Royer; J Levy
Determination of yohimbine and its two hydroxylated metabolites in humans by high-performance liquid chromatography and mass spectral analysis.
Journal of chromatography 1992;574(2):283-92.
1992: Pascal Le Corre; Yannick Malledant; François Chevanne; P Sado; Roger Le Verge
Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans.
Chirality 1992;4(2):80-3.
1991: Pascal Le Corre; P Sado; Roger Le Verge
[The effect of chirality in clinical pharmacology].
Journal de pharmacie de Belgique 1991;46(5):331-47.
1991: Pascal Le Corre; D Gibassier; P Sado; Roger Le Verge
Human pharmacokinetics and metabolism of disopyramide enantiomers.
European journal of drug metabolism and pharmacokinetics 1991;Spec No 3():233-7.
1991: Pascal Le Corre; D Ratanasavanh; François Chevanne; D Gibassier; P Sado; Roger Le Verge; A Guillouzo
In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data.
Chirality 1991;3(5):405-11.
1989: Pascal Le Corre; D Gibassier; C Descaves; P Sado; Jean-Claude Daubert; Roger Le Verge
Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
Journal of clinical pharmacology 1989;29(12):1089-96.
1989: A Rolland; B Collet; Roger Le Verge; Louis Toujas
Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice.
Journal of pharmaceutical sciences 1989;78(6):481-4.
1988: Pascal Le Corre; D Gibassier; P Sado; Roger Le Verge
Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
Drug metabolism and disposition: the biological fate of chemicals 1988;16(6):858-64.
1988: Pascal Le Corre; D Gibassier; P Sado; Roger Le Verge
Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man.
Journal of chromatography 1988;450(2):211-6.
1988: Pascal Le Corre; D Gibassier; P Sado; Roger Le Verge
Simultaneous assay of disopyramide and monodesisopropyldisopyramide enantiomers in biological samples by liquid chromatography.
Journal of chromatography 1988;424(2):424-9.
1988: D Bourel; A Rolland; Roger Le Verge; B Genetet
A new immunoreagent for cell labeling. CD3 monoclonal antibody covalently coupled to fluorescent polymethacrylic nanoparticles.
Journal of immunological methods 1988;106(2):161-7.
1987: A Rolland; G Merdrignac; J Gouranton; D Bourel; Roger Le Verge; B Genetet
Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles.
Journal of immunological methods 1987;96(2):185-93.
1987: Michèle Tanguy; Yannick Malledant; Roger Le Verge; D Gibassier; C Saint-Marc
[Prolonged intravenous infusion of morphine. Pharmacokinetic study].
Annales françaises d'anesthèsie et de rèanimation 1987;6(1):22-8.
1986: Philippe Maincent; Roger Le Verge; P Sado; P Couvreur; Jean-Philippe Devissaguet
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
Journal of pharmaceutical sciences 1986;75(10):955-8.
1986: A Rolland; D Gibassier; P Sado; Roger Le Verge
[Methodology for the preparation of nanoparticulate vectors with an acrylic polymer base].
Journal de pharmacie de Belgique 1986;41(2):83-93.
1985: P A Sado; D Gibassier; Roger Le Verge; Daniela Acerbi; Piero Schiantarelli
[Relative bioavailability of vinburnine in man (microgranules/gels)].
Journal de pharmacie de Belgique 1985;40(5):308-22.
1984: A Rolland; D Gibassier; C Chemtob; Roger Le Verge
[Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
Journal de pharmacie de Belgique 1984;39(3):136-44.
1984: A Rolland; D Gibassier; C Chemtob; Roger Le Verge
[Comparative study of the in vitro availability of vincamine from delayed-release forms. 1].
Journal de pharmacie de Belgique 1984;39(2):93-9.
1981: J P Koskas; P A Sado; Jean-Philippe Devissaguet; Roger Le Verge
[Absolute bioavailability of an aqueous solution of quinidine administered orally to the rat and evaluation of the enterohepatic cycle (author's transl)].
Journal de pharmacie de Belgique 1981;36(3):193-9.
1981: J P Koskas; P A Sado; Jean-Philippe Devissaguet; Roger Le Verge
[Application of a micromethod for sampling and for the specific quantitative evaluation of quinidine. I. Pharmacokinetic study after intravenous administration in the rat (author's transl)].
Journal de pharmacie de Belgique 1981;36(3):187-92.